X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder caused by a mutation in the ATP-binding cassette transporter subfamily D member 1 (ABCD1) gene. We generated two induced pluripotent stem cell (iPSC) lines from X-ALD patients with adrenomyeloneuropathy (AMN) by Sendai virus containing OCT4, SOX2, KLF4 and c-MYC. Established iPSC lines expressed various pluripotency markers, had differentiation potential of three germ layers in vitro, had normal karyotype and retained ABCD1 mutation.
Resource utility
These iPSC lines (YUSEVi005-A and YUSEVi006-A) will be useful for modeling X-ALD disease and developing drugs to treat this disease.
Resource details
X-linked adrenoleukodystrophy (X-ALD) is an inherited disorder caused by ATP-binding cassette transporter subfamily D member 1 (ABCD1) gene mutation (Mosser et al., 1993) . Two human fibroblast cells from X-ALD patients with ABCD1 mutation were reprogrammed into iPSCs by Sendai virus containing OCT4, SOX2, KLF4, and c-MYC (Fig. 1A , Table 1 ). The established iPSC lines (YUSEVi005-A and YUSEVi006-A) expressed various pluripotency markers including OCT4, NANOG, and TRA-1-81 (Fig. 1B-C) . One patient harboured one allele transition (G N A) of ABCD1 gene, which substituted Serine for Glycine at codon 512, as verified by genomic DNA sequencing of ABCD1 in YUSEVi005-A. The other patient harboured a deletion of three nucleotides of ABCD1 gene at codon 657 as verified by genomic DNA sequencing of ABCD1 in YUSEVi006-A (Fig. 1D ). YUSEVi005-A and YUSEVi006-A could differentiate into cells of the three embryonic germ layers in vitro ( Fig. 1E) , had a normal karyotype without abnormalities in the number or structure of chromosomes (Fig. 1F ), and were negative for Mycoplasma contamination (Fig. 1G) . STR analysis showed that parental Stem Cell Research 25 (2017) Table 2 ).
Materials and methods

Cell culture
Human fibroblasts were isolated from patients carrying a ABCD1 mutation and cultured in growth media (GM; DMEM supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin, 2 nM Lglutamine) at 37°C in 5% CO 2 .
Generation of iPSC from X-ALD patient fibroblasts X-ALD patient fibroblasts were reprogrammed to iPSC using CytoTune™-iPS 2.0 Sendai Reprogramming Kit (Invitrogen) according to the manufacturer's instructions. After transduction, cells were reseeded on mouse embryonic fibroblast (STO) feeder cells (ATCC CRL-1503) and cultured in conventional human embryonic stem cell medium (Jang et al., 2011) for 30 days.
Immunocytochemistry
The iPSC lines (YUSEVi005-A and YUSEVi006-A) were fixed in 4% paraformaldehyde, incubated with primary antibodies overnight at 4°C
, and then incubated with secondary antibodies for 1 h at room temperature. Nuclei were stained with DAPI for 5 min at room temperature. Immunofluorescence was visualized under fluorescence microscope (Olympus IX71) (Table 3) .
Flow cytometry analysis
The iPSC lines (YUSEVi005-A and YUSEVi006-A) were dissociated with accutase, blocked with 10% FBS for 30 min at 4°C, incubated with a primary antibody for 1 h at 4°C and then incubated with a secondary antibody for 1 h at 4°C. Expression of surface marker of pluripotency was analysed by FACSVerse flow cytometer (BD (Table 3) .
In vitro differentiation
The iPSC lines (YUSEVi005-A and YUSEVi006-A) were cultured in chemically defined reprogramming medium (Chen et al., 2011) without basic fibroblast growth factor and transforming growth factor β for 3 days and then in the specified differentiation medium for 10 days. For ectodermal differentiation, cells were cultured in DMEM/F12 (Lonza) supplemented with 1× N2 (Thermo Fisher Scientific), 1× B27 (Thermo Fisher Scientific), 10 ng/ml of leukemia inhibitory factor (Millipore), 2 μM SB431542 and 3 μM CHIR99021. For mesodermal differentiation, cells were cultured in Advanced-RPMI (Thermo Fisher Scientific) supplemented with 8 μM CHIR99021. For endodermal differentiation, cells were cultured in DMEM-low glucose (Hyclone) supplemented with 10% FBS (Hyclone). The in vitro differentiation potential of the iPSC lines was confirmed by immunocytochemistry (Table 3) .
Sequencing analysis of the ABCD1 mutant alleles and karyotyping
Genomic DNA was isolated from the iPSC lines using a Wizard® Genomic DNA Purification Kit (Promega). Mutation sequencing of AMN5 and AMN6 were performed using AMN5 and AMN6-specific primers (Table 3) . Karyotyping was performed by GTG banding by Samkwang Medical Laboratories.
Mycoplasma contamination detection
The absence of mycoplasma contamination was confirmed using MycoAlert™ PLUS Mycoplasma Detection kit (Lonza).
STR analysis
Parent fibroblasts and their established iPSC lines (YUSEVi005-A and YUSEVi006-A) were authenticated using STR analysis by Cosmo Genetech. 
